Search results for: axial spondyloarthritis

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD | May 1, 2014

How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved

EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

Thomas R. Collins | September 1, 2013

Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored

Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients

Staff | September 1, 2013

The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants

ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease

Thomas R. Collins | December 1, 2012

More finely tuned view of ankylosing spondylitis leads to better treatment, expert says

Health Professionals Bound for Chicago

Staff | August 1, 2011

The 2011 ACR/ARHP Annual Meeting program offers a plethora of opportunities for health professionals to gain insight into emerging concepts in the diagnosis and treatment of rheumatologic disorders as well as improving quality of life in affected patients.

The Classification Challenge of Pediatric Spondylarthritis

Robert A. Colbert, MD, PhD | April 1, 2010

Condition often confused with other disorders

From Basic Science to Clinical Treatments: An Update on PsA

Jason Liebowitz, MD, FACR | November 16, 2023

Dr. Christopher Ritchlin provided insights into the underlying mechanisms of the immune system that promote disease activity in patients with psoriatic arthritis (PsA), the latest research on how to optimize therapy for PsA and more.

Growing Up

Jason Liebowitz, MD, FACR | November 14, 2023

SAN DIEGO—In the pre-ACR Convergence 2023 Review Course, Rebecca Sadun, MD, PhD, assistant professor in medicine and pediatrics, Duke University School of Medicine, Durham, N.C., focused on transitions from pediatric to adult rheumatology care for patients with juvenile idiopathic arthritis (JIA).

When Rheumatic Disease May Have Affected the Course of Western Civilization

Baljeet Rai, MD, Abhimanyu Amarnani, MD, PhD, Ja-Yoon Uni Choe, MD, Nicole K. Zagelbaum Ward, DO, MPH, & Richard S. Panush, MD, MACP, MACR | November 8, 2022

The study of rheumatology (and medicine) in art, history, literature and music is engaging and informative.1-12 In this article, we present some instances when rheumatic and autoimmune diseases in certain individuals may have affected the course of history in Western civilization. Physicians are usually concerned, appropriately, with the effects of illness on the lives of…

Back to Basics: RheumMadness 2022 Increasing ANA Positivity Scouting Report

University of Chicago School of Medicine: Lauren He, MD; Ana B. Arevalo, MD; & Kichul Ko, MD | March 3, 2022

Research has revealed how the prevalence of anti-nuclear antibody (ANA) positivity has changed over the past 25 years, raising questions about the role of ANA in autoimmunity and disease.